Nanostring Technologies CEO Perry Fell has resigned as CEO, and has been replaced on an acting basis by chief financial officer Wayne Burns. The Seattle-based company, which makes instruments that provide a digital readout for large-scale genomic experiments, shipped its first commercial product in July. The company was founded in 2004, and has raised $17 million from OVP Venture Partners and Draper Fisher Jurvetson. Fell will retain a board seat, said Sara Morris, a spokeswoman for OVP.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
